aurintricarboxylic acid has been researched along with cosalane in 25 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 11 (44.00) | 18.2507 |
2000's | 11 (44.00) | 29.6817 |
2010's | 3 (12.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cushman, M; De Clercq, E; Golebiewski, WM; Graham, L; Mazumder, A; Pommier, Y; Reymen, D; Rice, WG | 1 |
Bader, JP; Buckheit, RW; Clanton, DJ; Cushman, M; Golebiewski, WM; Graham, L; Haugwitz, RD; McMahon, JB; Rice, WG; Weislow, O | 1 |
Choo, V | 1 |
Cushman, M; Golebiewski, WM; Keyes, RF | 2 |
Buckheit, RW; Cushman, M; Fliakas-Boltz, V; Golebiewski, WM; Graham, L; Rice, WG; Turpin, JA | 1 |
Anderson, BD; Li, J; Venkatesh, S; Vishnuvajjala, R; Xu, Y | 1 |
Gabriel, JL; Mitchell, WM | 1 |
Cushman, M; Insaf, S; Rice, WG; Ruell, JA; Schaeffer, CA | 1 |
Cushman, M; De Clercq, E; Insaf, S; Pannecouque, C; Paul, G; Rice, WG; Ruell, JA; Schaeffer, CA; Schols, D; Turpin, JA; Williamson, K; Witvrouw, M | 1 |
Badr, MZ; Mitra, AK; Udata, C | 1 |
Johnston, TP; Kuchimanchi, KR; Mitra, AK; Udata, C | 1 |
Mitra, AK; Pal, D; Udata, C | 1 |
Buckheit, RW; Casimiro-Garcia, A; Cushman, M; De Clercq, E; Pannecouque, C; Stup, TL; Turpin, JA; Witvrouw, M | 1 |
Buckheit, RW; Cushman, M; De Clercq, E; Loftus, TL; Pannecouque, C; Paul, GC; Turpin, JA; Witvrouw, M | 1 |
Buckheit, RW; Cushman, M; De Clercq, E; Loftus, TL; Pannecouque, C; Santhosh, KC; Turpin, JA; Witvrouw, M | 1 |
Cushman, M; Dong, HF; Howard, OM; Insaf, S; Oppenheim, JJ; Paul, G; Santhosh, KC | 1 |
Buckheit, RW; Cushman, M; De Clercq, E; Loftus, TL; Pannecouque, C; Paul, GC; Santhosh, KC; Turpin, JA; Witvrouw, M | 1 |
Ahmed, MS; Johnston, TP; Kuchimanchi, KR; Mitra, AK | 1 |
Buckheit, RW; Casimiro-Garcia, A; Cushman, M; De Clercq, E; Fanwick, PE; Loftus, TL; Pannecouque, C; Turpin, JA; Witvrouw, M | 1 |
Cushman, M; Gandhi, MD; Johnston, TP; Kuchimanchi, KR; Mitra, AK; Santhosh, KC; Sheta, RR | 1 |
Cushman, M; Hejchman, E; Mitra, AK; Pal, D; Patel, J; Udata, C | 1 |
Li, Z; Liu, X; Zhan, P | 1 |
Coghill, JM; Fowler, KA; Hull-Ryde, EA; Janzen, W; Kireev, D; Li, K; Pearce, KH; Porter, MA; Sassano, MF; Simpson, CD; Suto, MJ | 1 |
Aubé, J; Bruce, DW; Coghill, JM; Fowler, KA; Li, K; Moorman, NJ; Whitehurst, CB | 1 |
1 review(s) available for aurintricarboxylic acid and cosalane
Article | Year |
---|---|
Cosalane and its analogues: a unique class of anti-HIV agents.
Topics: Anti-HIV Agents; Aurintricarboxylic Acid; CD4 Antigens; HIV Envelope Protein gp120; Humans; Reverse Transcriptase Inhibitors; Structure-Activity Relationship | 2010 |
24 other study(ies) available for aurintricarboxylic acid and cosalane
Article | Year |
---|---|
Cosalane analogues with enhanced potencies as inhibitors of HIV-1 protease and integrase.
Topics: Amino Acid Sequence; Antiviral Agents; Aurintricarboxylic Acid; Cell Line; DNA Nucleotidyltransferases; Herpesviridae; HIV Protease Inhibitors; HIV-1; Humans; Integrases; Microbial Sensitivity Tests; Molecular Sequence Data; Virus Replication | 1995 |
Design, synthesis, and biological evaluation of cosalane, a novel anti-HIV agent which inhibits multiple features of virus reproduction.
Topics: Antiviral Agents; Aurintricarboxylic Acid; B-Lymphocytes; Cell Fusion; Cells, Cultured; DNA, Viral; HeLa Cells; HIV Infections; HIV-1; Humans; Macrophages; Phenotype; T-Lymphocytes; Virion; Virus Replication; Zidovudine | 1994 |
Anti-HIV activity of cosalane.
Topics: Antiviral Agents; Aurintricarboxylic Acid; Cells, Cultured; HIV-1; HIV-2; Humans | 1993 |
Correlation of anti-HIV potency with lipophilicity in a series of cosalane analogs having normal alkenyl and phosphodiester chains as cholestane replacements.
Topics: Antiviral Agents; Aurintricarboxylic Acid; Cells, Cultured; Cytopathogenic Effect, Viral; HIV-1; Humans; Lipid Metabolism; Spectrum Analysis | 1996 |
Synthesis and biological evaluation of certain alkenyldiarylmethanes as anti-HIV-1 agents which act as non-nucleoside reverse transcriptase inhibitors.
Topics: Amino Acid Sequence; Antiviral Agents; Aurintricarboxylic Acid; Benzoates; Binding Sites; Biphenyl Compounds; Cells, Cultured; Didanosine; Drug Resistance, Microbial; HIV Core Protein p24; HIV Reverse Transcriptase; HIV-1; Magnetic Resonance Spectroscopy; Mass Spectrometry; Molecular Sequence Data; Molecular Structure; Mutagenesis, Site-Directed; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase | 1996 |
Intrinsic solubility estimation and pH-solubility behavior of cosalane (NSC 658586), an extremely hydrophobic diprotic acid.
Topics: Anti-HIV Agents; Aurintricarboxylic Acid; Chemical Phenomena; Chemistry, Physical; Hydrogen-Ion Concentration; Ions; Kinetics; Solubility | 1996 |
Exploration of the effects of linker chain modifications on anti-HIV activities in a series of cosalane analogues.
Topics: Anti-HIV Agents; Antiviral Agents; Aurintricarboxylic Acid; Models, Molecular; Phosphorylation; Structure-Activity Relationship | 1996 |
Functional design of potential inhibitors of human immunodeficiency virus (HIV) binding to CD4+ target cells: a molecular model of gp120 predicts ligand binding.
Topics: Aurintricarboxylic Acid; Binding Sites; CD4 Antigens; Computer Simulation; Drug Design; HIV; HIV Envelope Protein gp120; Ligands; Models, Molecular; Suramin; Tannins | 1996 |
Synthesis of a cosalane analog with an extended polyanionic pharmacophore conferring enhanced potency as an anti-HIV agent.
Topics: Anti-HIV Agents; Aurintricarboxylic Acid; CD4 Antigens; Drug Design; HIV-1; Humans; Models, Molecular; Molecular Conformation; Molecular Structure; Protein Conformation; Structure-Activity Relationship; Tumor Cells, Cultured | 1998 |
Extension of the polyanionic cosalane pharmacophore as a strategy for increasing anti-HIV potency.
Topics: Animals; Anti-HIV Agents; Aurintricarboxylic Acid; Benzoates; CD4 Antigens; Cell Line; Cholestanes; HIV-1; HIV-2; Humans; Models, Molecular; Protein Binding; Structure-Activity Relationship | 1999 |
Disposition of cosalane, a novel anti-HIV agent, in isolated perfused rat livers.
Topics: Animals; Anti-HIV Agents; Aurintricarboxylic Acid; Chromatography, High Pressure Liquid; Enzyme Induction; In Vitro Techniques; L-Lactate Dehydrogenase; Liver; Male; Protein Binding; Rats; Rats, Sprague-Dawley | 1999 |
Pharmacokinetics, biliary excretion, and tissue distribution of novel anti-HIV agents, cosalane and dihydrocosalane, in Sprague-Dawley rats.
Topics: Administration, Oral; Animals; Anti-HIV Agents; Aurintricarboxylic Acid; Bile; Chromatography, High Pressure Liquid; Enterohepatic Circulation; Injections, Intravenous; Male; Models, Biological; Rats; Rats, Sprague-Dawley; Spectrophotometry, Ultraviolet; Tissue Distribution | 2000 |
Transport of cosalane-a highly lipophilic novel anti-HIV agent-across caco-2 cell monolayers.
Topics: Anti-HIV Agents; Aurintricarboxylic Acid; Biological Availability; Caco-2 Cells; Humans; Solubility | 2000 |
Synthesis and anti-HIV activity of cosalane analogues incorporating nitrogen in the linker chain.
Topics: Anti-HIV Agents; Aurintricarboxylic Acid; Cell Line; Cytopathogenic Effect, Viral; HIV-1; HIV-2; Humans; Magnetic Resonance Spectroscopy; Nitrogen; Spectrometry, Mass, Fast Atom Bombardment | 2000 |
Identification of optimal anion spacing for anti-HIV activity in a series of cosalane tetracarboxylates.
Topics: Anti-HIV Agents; Aurintricarboxylic Acid; Carboxylic Acids; CD4 Antigens; Cell Line; Cell Survival; HIV-1; HIV-2; Humans; Models, Molecular; Protein Binding; Structure-Activity Relationship | 2000 |
Anti-HIV activity of a series of cosalane amino acid conjugates.
Topics: Amino Acids; Anti-HIV Agents; Aurintricarboxylic Acid; CD4 Antigens; Cell Line; Humans; Microbial Sensitivity Tests | 2000 |
Inhibition of RANTES/CCR1-mediated chemotaxis by cosalane and related compounds.
Topics: Acetylation; Anti-HIV Agents; Aurintricarboxylic Acid; Cell Line; Chemokine CCL5; Chemokine CXCL12; Chemokines, CXC; Chemotaxis; Humans; Lymphocytes; Molecular Structure; Protein Binding; Receptors, CCR1; Receptors, Chemokine; Transfection | 2001 |
Correlation of anti-HIV activity with anion spacing in a series of cosalane analogues with extended polycarboxylate pharmacophores.
Topics: Anions; Anti-HIV Agents; Aurintricarboxylic Acid; CD4 Antigens; Cell Line; HIV-1; Humans; Models, Molecular; Structure-Activity Relationship | 2001 |
Binding of cosalane--a novel highly lipophilic anti-HIV agent--to albumin and glycoprotein.
Topics: Animals; Anti-HIV Agents; Aurintricarboxylic Acid; Blood Proteins; Cattle; Chromatography, Gel; Humans; Mucins; Orosomucoid; Rats; Serum Albumin; Serum Albumin, Bovine | 2001 |
Synthesis and anti-HIV activity of cosalane analogues incorporating two dichlorodisalicylmethane pharmacophore fragments.
Topics: Anti-HIV Agents; Aurintricarboxylic Acid; CD4 Antigens; Cell Survival; Drug Design; HIV Envelope Protein gp120; HIV-1; HIV-2; Humans; Inhibitory Concentration 50; Salicylates; Structure-Activity Relationship; Tumor Cells, Cultured | 2001 |
Intestinal absorption and biodistribution of cosalane and its amino acid conjugates: novel anti-HIV agents.
Topics: Animals; Anti-HIV Agents; Aurintricarboxylic Acid; Intestinal Absorption; Male; Rats; Rats, Sprague-Dawley; Tissue Distribution | 2002 |
Enhanced transport of a novel anti-HIV agent--cosalane and its congeners across human intestinal epithelial (Caco-2) cell monolayers.
Topics: Anti-HIV Agents; Aurintricarboxylic Acid; Biological Transport; Caco-2 Cells; Cyclodextrins; Glycerol; Humans; Permeability; Solubility | 2003 |
Identification of Cosalane as an Inhibitor of Human and Murine CC-Chemokine Receptor 7 Signaling via a High-Throughput Screen.
Topics: Animals; Aurintricarboxylic Acid; Cell Line; Chemotaxis; Drug Design; High-Throughput Screening Assays; Humans; Ligands; Mice; Molecular Structure; Receptors, CCR7; Receptors, G-Protein-Coupled; Signal Transduction; Structure-Activity Relationship; T-Lymphocytes | 2018 |
The Ex Vivo Treatment of Donor T Cells with Cosalane, an HIV Therapeutic and Small-Molecule Antagonist of CC-Chemokine Receptor 7, Separates Acute Graft-versus-Host Disease from Graft-versus-Leukemia Responses in Murine Hematopoietic Stem Cell Transplanta
Topics: Acute Disease; Animals; Aurintricarboxylic Acid; Graft vs Host Disease; Graft vs Leukemia Effect; Hematopoietic Stem Cell Transplantation; Humans; Mice; Receptors, CCR7; T-Lymphocytes; Tissue Donors; Transplantation Conditioning | 2019 |